Search

A report from the Swiss Federal Institute of Technology Lausanne (EPFL) discusses the potential for using in-memory sensing and computing in cancer diagnostics. The report examines the use of two-terminal switching devices, known as memristive devices, which have hysteric behavior in current-to-voltage characteristics. These devices have applications in data storage, in-memory computing, and in-sensor computing. The report explores the concept of using multiple cancer markers simultaneously to improve diagnostic processes in cancer medicine. The research was supported by the Swiss National Science Foundation and has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at the Vellore Institute of Technology in Tamil Nadu, India, explores the concept of biographical renewal in cancer survivorship. The study highlights the positive transformations that can occur after cancer and emphasizes the importance of considering biographical renewal as a goal in survivorship care plans. The researchers suggest that healthcare professionals, caregivers, and palliative care providers should strive to foster an understanding of biographical renewal to provide comprehensive care and improve patients' quality of life. The study's findings are published in the Indian Journal of Palliative Care. [Extracted from the article]

Queen's University researchers have developed an educational resource for gynecological cancer survivors and their caregivers. The resource was created through a patient-clinician-researcher partnership and involved five phases, including assembling expertise, reviewing literature, drafting the resource, testing it, and disseminating it. The researchers used diverse partnerships and multiple research methods to create a resource that fills a procedural gap for clinicians and researchers looking to develop empirically and experientially founded educational resources. For more information, readers can refer to the article "Developing an educational resource for gynecological cancer survivors and their caregivers: A methods and experience paper" in the Canadian Oncology Nursing Journal. [Extracted from the article]

A recent preprint abstract highlights the issue of misidentified reagents in cancer research papers. The study found that a significant number of papers studying miR-145 had misidentified nucleotide sequence reagents and human cell lines. Additionally, the researchers discovered non-verifiable cell line identifiers that were not indexed in accessible repositories. This raises concerns about the reproducibility of research and calls for further investigation into the identities of these cell lines. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at the University of Campania in Naples, Italy, focused on the role of circulating microRNAs (c-miRNAs) in cancer research, specifically breast cancer (BC) and lung cancer (LC). The study analyzed over 150 papers published between 2018 and 2023, highlighting the effectiveness of c-miRNAs in areas such as early detection, therapeutic resistance, recurrence risk, and novel detection platforms. The researchers also examined the deregulated c-miRNAs shared between BC and LC papers, with a particular focus on miR-21 and miR-145. The study concludes that c-miRNAs in cancer research remain a significant topic of interest, with blood being the most investigated matrix. [Extracted from the article]

A recent report discusses research findings on cancer informatics, specifically focusing on significant contributions published in 2022. The research conducted an extensive search using PubMed/MEDLINE to identify the best papers in the field. The three selected best papers highlight advancements in federated learning, drug synergy prediction, and the utilization of clinical note data. The report concludes that cancer informatics is maturing as a subfield of biomedical informatics, with notable applications in data sharing and federated approaches. For more information, readers can refer to the Yearbook of Medical Informatics. [Extracted from the article]

A recent systematic review conducted by researchers at the University of Calgary aimed to identify prognostic factors in patients with advanced cancer who receive palliative radiotherapy. The review analyzed 57 papers and identified several clinical and biological prognostic factors that can aid in clinical decision making and improve prognosis. The study also found evidence supporting the use of prognostic models and the importance of certain biological factors. The researchers recommend further validation of these tools and factors in a clinical setting, as well as the inclusion of prediction of response to radiation as an outcome in future studies. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the issue of intratumoral heterogeneity in tumor progression, which occurs when genetically distinct subclones emerge. These subclones are characterized by different types of somatic genomic aberrations, with single nucleotide variants (SNVs) and copy number aberrations (CNAs) being the most prominent. The paper introduces a method called DETOPT, which aims to accurately infer tumor progression trees by placing SNVs impacted by CNAs on these trees. The method is shown to provide more accurate tree placement of SNVs impacted by CNAs compared to existing alternatives. The paper also applies DETOPT to a set of tumor metastases from a treatment-refractory, triple-positive metastatic breast cancer, reporting biologically plausible trees of tumor progression. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A new editorial paper published in Oncotarget discusses acute myeloid leukemia (AML), a type of aggressive cancer. The paper highlights recent advancements in understanding AML biology and the potential for developing novel drug therapies. The researchers suggest exploring reductive carboxylation as a possible drug target to weaken tumor cell survival mechanisms and improve patient outcomes. The paper provides further information on this topic and can be accessed through the provided DOI link. [Extracted from the article]

A recent study conducted by researchers at the First People's Hospital of Foshan examined the diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer. The study analyzed multiple papers and found that both double contrast-enhanced gastric ultrasonography (D-CEGUS) and oral contrast-enhanced gastric ultrasonography (O-CEGUS) were effective in differentiating between T1 and T2 gastric cancer. The researchers concluded that O-CEGUS, due to its simplicity and cost-effectiveness, is often preferred as a staging method for gastric cancer before endoscopic intervention. This study provides valuable insights for clinicians in formulating treatment strategies for patients with early gastric cancer. [Extracted from the article]